CN107823622A - A kind of pharmaceutical composition for treating cold urticaria and its production and use - Google Patents
A kind of pharmaceutical composition for treating cold urticaria and its production and use Download PDFInfo
- Publication number
- CN107823622A CN107823622A CN201711353257.5A CN201711353257A CN107823622A CN 107823622 A CN107823622 A CN 107823622A CN 201711353257 A CN201711353257 A CN 201711353257A CN 107823622 A CN107823622 A CN 107823622A
- Authority
- CN
- China
- Prior art keywords
- parts
- pharmaceutical composition
- cold urticaria
- bulk drug
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010009869 cold urticaria Diseases 0.000 title claims abstract description 28
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 26
- 238000004519 manufacturing process Methods 0.000 title description 3
- 239000003814 drug Substances 0.000 claims abstract description 33
- 229940079593 drug Drugs 0.000 claims abstract description 22
- 238000002360 preparation method Methods 0.000 claims abstract description 16
- 241000132012 Atractylodes Species 0.000 claims abstract description 9
- 241000255789 Bombyx mori Species 0.000 claims abstract description 9
- 241000931705 Cicada Species 0.000 claims abstract description 9
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 9
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 9
- 241001465251 Ephedra sinica Species 0.000 claims abstract description 9
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 9
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 9
- 235000017443 Hedysarum boreale Nutrition 0.000 claims abstract description 9
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims abstract description 9
- 239000009636 Huang Qi Substances 0.000 claims abstract description 9
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 9
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 9
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims abstract description 9
- 241001521901 Tribulus lanuginosus Species 0.000 claims abstract description 8
- 230000000295 complement effect Effects 0.000 claims abstract description 7
- 244000170916 Paeonia officinalis Species 0.000 claims abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- -1 decoction Substances 0.000 claims description 2
- 229940040145 liniment Drugs 0.000 claims description 2
- 239000000865 liniment Substances 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- 244000273928 Zingiber officinale Species 0.000 claims 1
- 235000006886 Zingiber officinale Nutrition 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 235000008397 ginger Nutrition 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 abstract description 3
- 235000019634 flavors Nutrition 0.000 abstract description 3
- 208000003251 Pruritus Diseases 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 208000024780 Urticaria Diseases 0.000 description 7
- 241000736199 Paeonia Species 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 238000009835 boiling Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 210000002683 foot Anatomy 0.000 description 4
- 206010040882 skin lesion Diseases 0.000 description 4
- 231100000444 skin lesion Toxicity 0.000 description 4
- 210000003423 ankle Anatomy 0.000 description 3
- 229960001140 cyproheptadine Drugs 0.000 description 3
- JJCFRYNCJDLXIK-UHFFFAOYSA-N cyproheptadine Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2C=CC2=CC=CC=C21 JJCFRYNCJDLXIK-UHFFFAOYSA-N 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 2
- 208000031975 Yang Deficiency Diseases 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000001387 anti-histamine Effects 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 235000014102 seafood Nutrition 0.000 description 2
- 235000021147 sweet food Nutrition 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 241000173529 Aconitum napellus Species 0.000 description 1
- 206010003497 Asphyxia Diseases 0.000 description 1
- 240000006122 Chenopodium album Species 0.000 description 1
- 235000009344 Chenopodium album Nutrition 0.000 description 1
- 108010091326 Cryoglobulins Proteins 0.000 description 1
- 206010011953 Decreased activity Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- JAUOIFJMECXRGI-UHFFFAOYSA-N Neoclaritin Chemical compound C=1C(Cl)=CC=C2C=1CCC1=CC=CN=C1C2=C1CCNCC1 JAUOIFJMECXRGI-UHFFFAOYSA-N 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 241000144958 Piaractus mesopotamicus Species 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 206010046751 Urticaria physical Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002333 angiotensin II receptor antagonist Substances 0.000 description 1
- 229940125364 angiotensin receptor blocker Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 235000021270 cold food Nutrition 0.000 description 1
- 230000002153 concerted effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229960001271 desloratadine Drugs 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229960003088 loratadine Drugs 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 201000002881 physical urticaria Diseases 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000009571 yupingfeng Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of pharmaceutical composition for treating cold urticaria, and it is made up of the bulk drug of following weight proportion：25 30 parts of the Radix Astragali, 15 20 parts of the bighead atractylodes rhizome, windproof 10 15 parts, Chinese ephedra 5 10,10 15 parts of cassia twig, 5 10 parts of RADIX ACONITI LATERALIS PREPARATA, 15 parts of rhizoma zingiberis, 10 15 parts of Radix Angelicae Sinensis, 10 15 parts of Ligusticum wallichii, 15 20 parts of the root of herbaceous peony, 10 15 parts of stiff silkworm, 10 15 parts of cicada slough, 10 15 parts of tribulus terrestris, 10 15 parts of honey-fried licorice root.Present invention also offers the preparation method of aforementioned pharmaceutical compositions and purposes.Pharmaceutical composition of the present invention, compatibility is precise and appropriate, and each flavour of a drug complement each other, and to alleviating cold urticaria conditions of patients, preventing from recurring evident in efficacy, can more effectively treat cold urticaria, new selection is provided for clinical application.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition for treating cold urticaria and its production and use.
Background technology
Cold urticaria (cold urticaria, CU) is one kind of physical urticaria, shows as receiving cold stimulation
After break out, severe patient can suffer a shock, threat to life.It is divided into acquired and familial according to heredity is whether there is.Acquired cold
Property nettle rash (acquired cold urticaria, ACU) is divided into primary (primary acquired cold again
Urticaria, PACU) and the major class of Secondary cases 2, the former is most common, accounts for 72%~96%；The latter is mostly occurred in cryoglobulin blood
On the disease of the basis such as disease, cold fibremia, CTD.
TCM thinks that this cause of disease affection by exopathogenic cold-wind, space between skin and muscles occlusion, qi depression to blood stasis, channels knot, which gather, to be formed；Or due to yang-energy
Deficiency, qi and blood two is empty, and skin is lost in warm, feels the heresy of chill, fleshy exterior of controlling long again；Or due to instability of surface, battalion, which defends, to become estranged, chill
Heresy take advantage of a weak point, visitor in skin space between skin and muscles, make to gather through kank, the ying blood stasis of blood is stagnant and falls ill.This sick initial stage shows the deficiency of vital energy more, can enter one
Step develops into the deficiency of yang, the long then qi deficiency to blood stasis of disease, therefore this sick basic pathogenesis is asthenia in origin and asthenia in superficiality, and the heart qi deficiency, spleen, kidney-yang deficiency are this,
Blood stasis is marks, long then simulataneous insufficiency and excessive.
Western medical treatment is more mainly based on the application of antihistamine, but clinical efficacy differs.Cyproheptadine is recognized always in the past
To be the first choice for treating cold urticaria, but more recently by facts have proved that cyproheptadine (cyproheptadine), ketoboidies be fragrant, oral color
Sweet acid sodium, H2 ARBs can only achieve the purpose temporarily controlled, stop to cold urticaria patient outcome and bad
Easily recurrence even symptom aggravates earlier above after medication, i.e., western medical treatment is basic without it is ruled by law, and easily recurrence.
Chinese medicine is with a long history, and patient acceptability is good.A kind of prescription effectively treated is needed badly to treat this disease, is alleviated
Itch and skin lesion, recurrent number is reduced, extend the paracmasis, make the life better patient quality.
The content of the invention
It is an object of the invention to provide a kind of pharmaceutical composition for treating cold urticaria.
Another object of the present invention is to provide the preparation method and purposes of described pharmaceutical composition.
The invention provides a kind of pharmaceutical composition for treating cold urticaria, and it is by the raw material of following weight proportion
Medicine is prepared：
Radix Astragali 25-30 parts, bighead atractylodes rhizome 15-20 parts, windproof 10-15 parts, Chinese ephedra 5-10, cassia twig 10-15 parts, RADIX ACONITI LATERALIS PREPARATA 5-10
Part, rhizoma zingiberis 1-5 parts, Radix Angelicae Sinensis 10-15 parts, Ligusticum wallichii 10-15 parts, root of herbaceous peony 15-20 parts, stiff silkworm 10-15 parts, cicada slough 10-15 parts, pierce puncture
Lamb's-quarters 10-15 parts, honey-fried licorice root 10-15 parts.
Preferably, aforementioned pharmaceutical compositions are prepared by the bulk drug of following weight proportion：
30 parts of the Radix Astragali, 15 parts of the bighead atractylodes rhizome, windproof 10 parts, 10 parts of Chinese ephedra, 10 parts of cassia twig, 10 parts of RADIX ACONITI LATERALIS PREPARATA, 5 parts of rhizoma zingiberis, Radix Angelicae Sinensis
10 parts, 10 parts of Ligusticum wallichii, 20 parts of the root of herbaceous peony, 10 parts of stiff silkworm, 10 parts of cicada slough, 15 parts of tribulus terrestris, 15 parts of honey-fried licorice root.
Aforementioned pharmaceutical compositions, it is the primary medicinal powder by the bulk drug, or water or extractive with organic solvent are work
Property composition, the preparation being prepared plus pharmaceutically acceptable auxiliary material or complementary composition.
The preparation is external preparation.
Preferably, the external preparation is lotion, decoction, liniment, powder or paste.
A kind of method for preparing aforementioned pharmaceutical compositions, it comprises the following steps：
B) bulk drug of each weight proportion is weighed；
B) by the primary medicinal powder of bulk drug, or water or extractive with organic solvent are active component, plus can pharmaceutically connect
The auxiliary material or complementary composition received are prepared into preparation.
Purposes of the aforementioned pharmaceutical compositions in the medicine for preparing treatment cold urticaria.
Cold urticaria of the present invention is the urticaria of the traditional Chinese medical science.
Further, skin lesion and itch of the cold urticaria for all cold urticaria patients.
Further, the cold urticaria includes yang deficiency of spleen and stomache, Qi deficiency blood stasis type, the blood-deficiency and wind-dry of the traditional Chinese medical science
Type.
Pharmaceutical composition of the present invention is by the Radix Astragali, bighead atractylodes rhizome, windproof, Chinese ephedra, cassia twig, RADIX ACONITI LATERALIS PREPARATA, rhizoma zingiberis, Radix Angelicae Sinensis, Ligusticum wallichii, white
Chinese herbaceous peony, stiff silkworm, cicada slough, tribulus terrestris, the four traditional Chinese medicine thing of honey-fried licorice root ten composition.
The big gas mended all over the body up and down of the Radix Astragali in side, bighead atractylodes rhizome invigorating the spleen dehumidifying, the windproof medicine of dispelling wind and arresting itching three go the meaning of Yupingfeng with
The solid table of wind-dispelling is antipruritic, treats both principal and secondary aspect of disease；Chinese ephedra opening pores space between skin and muscles so that ailment said due to cold or exposure is outgoing road.Cassia twig warming meridian, monkshood mend fire
It is supporing yang, rouse oneself kidney yang, the warm medicine of spleen three of conjunction rhizoma zingiberis shares passages through which vital energy circulates temperature and led to, and middle-jiao yang, function of the spleen and stomach rouses oneself, and life-gate fire excess makes a concerted effort to drive away cold-evil.Radix Angelicae Sinensis,
Ligusticum wallichii, promoting circulation of blood and enriching blood, mend and supply cloudy blood without the stagnant and root of herbaceous peony.Pathogen usually intruding into collateral in protracted disease event enters network with stiff silkworm, cicada slough worm medicine and picks heresy, tribulus terrestris
Soothing the liver calmness is antipruritic, honey-fried licorice root coordinating the drug actions of a prescription.
Pharmaceutical composition of the present invention, compatibility is precise and appropriate, and each flavour of a drug complement each other, to alleviate cold urticaria conditions of patients,
Prevent from recurring evident in efficacy, can more effectively treat cold urticaria, new selection is provided for clinical application.
According to the above of the present invention, according to the ordinary technical knowledge and customary means of relevant art, not
Under the premise of departing from the above-mentioned basic fundamental thought of the present invention, the modification, replacement or change of other diversified forms can also be made.
The embodiment of form by the following examples, the above of the present invention is remake further specifically
It is bright.But the scope that this should not be interpreted as to the above-mentioned theme of the present invention is only limitted to following example.It is all to be based on the above of the present invention
The technology realized belongs to the scope of the present invention.
Embodiment
The preparation of 1 pharmaceutical composition of the present invention of embodiment
1. raw material：Radix Astragali 30g, bighead atractylodes rhizome 15g, windproof 10g, Chinese ephedra 10g, cassia twig 10g, RADIX ACONITI LATERALIS PREPARATA 10g, rhizoma zingiberis 5g, Radix Angelicae Sinensis
10g, Ligusticum wallichii 10g, root of herbaceous peony 20g, stiff silkworm 10g, cicada slough 10g, tribulus terrestris 15g, honey-fried licorice root 15g.
2. preparation method：Weigh the bulk drug of above-mentioned weight proportion；Instrument material of boiling medicine is ceramics.Clear water 2000ml is taken,
Endured slowly with slow fire 15 minutes again after being boiled by fire.The dregs of a decoction are filtered out with gauze after boiling, the decoction endured is poured into foot bath
In, the appropriate cold water that adds makes decoction cover ankle, and temperature keeps 42-50 DEG C (a little higher than body temperature) to be advisable.
The preparation of 2 pharmaceutical composition of the present invention of embodiment
1. raw material：Radix Astragali 25g, bighead atractylodes rhizome 20g, windproof 15g, Chinese ephedra 5g, cassia twig 15g, RADIX ACONITI LATERALIS PREPARATA 5g, rhizoma zingiberis 1g, Radix Angelicae Sinensis
15g, Ligusticum wallichii 15g, root of herbaceous peony 15g, stiff silkworm 15g, cicada slough 15g, tribulus terrestris 10g, honey-fried licorice root 10g.
2. preparation method：Weigh the bulk drug of above-mentioned weight proportion；Instrument of boiling medicine is marmite.Take clear water 2500ml, big fire
Endured slowly with slow fire 20 minutes again after boiling.The dregs of a decoction are filtered out with gauze after boiling, the decoction endured is poured into foot bath, are fitted
Amount, which adds cold water, makes decoction cover ankle, and temperature keeps 42-50 DEG C (a little higher than body temperature) to be advisable.
Beneficial effects of the present invention are proved below by way of specific clinical test：
The clinical efficacy of the present composition of test example 1
1st, clinical data
Out-patient 67 is chosen, is met《Clinical dermatology》The diagnosis of relevant cold urticaria in fourth edition
Standard.
Sex and the range of age：Age 18-65 year, women 47, male 20 is total course of disease most short March, most long 35 years,
It is treatment time in most short January, most long 3 years.
All patients are randomly divided into two groups.The money such as treatment group 34, control group 33, two groups of patient ages, sex, courses of disease
Material compares no significant difference (P ＞ 0.05), has comparativity.
1.1 diagnostic criteria：
Clinical symptoms typical case, cold pressor test is positive, meets the clinical diagnosis of primary acquired cold urticaria, and 1
It is unused in month to cross Glucocorticoid, not used antihistamine, no serious organ and systemic disease in 4 days.
1.2 inclusive criteria
The case for meeting 1.1 section diagnostic criteria is included.
2nd, treatment method
Experimental group：Give the medicine of the embodiment of the present invention 1.
Specifically medication is：Night lavipeditum 1 time, both feet are put into foot bath by patient, to steep ankle as degree, immersion
20~30min, entire patient's low-grade fever, forehead or back is set to perspire slightly, lavipeditum terminates to use towel biped, one time a day, 4
Week is 1 course for the treatment of.During treatment, not equipped with other Western medicine and other therapies.
Control group：Only oral Loratadine (trade name：Clarityne) 10 milligrams, once a day.4 weeks are 1 course for the treatment of.
Diet is light during treatment, avoids delicious food savoury, avoids sweet food, seafood food and hot fruit, advises more food vegetables.The course for the treatment of
Terminate to carry out therapeutic evaluation, 8 weeks observation Repigmentation situations of clinical cure follow-up of patients.
3rd, observation of curative effect
3.1 criterion of therapeutical effect：
Curative effect judging standard is recorded by 4 grades of point systems, and standards of grading are as shown in table 1：
The standards of grading of table 1
| 0 point | 1 point | 2 points | 3 points | |
| Itch | Nothing | Slightly | Moderate | Severe |
| Wheal maximum gauge (centimetre) | Nothing | ＜ 0.5 | 0.5~2.0 | ＞ 2.0 |
| Wheal quantity (individual) | Nothing | 1~6 | 7~12 | ＞ 12 |
| Wheal seizure frequency (times/day) | Nothing | ＜ 3/ day | 3~4 times | ＞ 5 times |
In table 1, the grade classification on itch：0 point is：Without gargalesthesia；1 point is slightly：Itch occasionally has breaking-out, or only at night
Between or quiet environment under occur, and relatively limit to, mild degree, do not influence work and sleep；2 points of moderates are:Itch is frequently broken out, can
Occur simultaneously at number, degree is heavier, or even influences work and sleep；3 points of severes are:Itch is persistently broken out, in general hair, degree
Weight, influences work and sleep, can change with skin scratch, scab, pigmentation, eczema, liver mossization etc..
Symptom integral declines integration × 100% before index=(being integrated before treatment after integration-treatment)/treatment.
It is basic to cure integral exponential >=90%；Effective is >=60 but ＜ 90%；Take a turn for the better as >=20 but ＜ 60%；Invalid integration
For 20%.
Cure and effective percentage adds up to effective percentage.
3.2 treatment results
As shown in table 2, table 3
The effect for the treatment of group example patient of table 2 is after treatment in 4 weeks
| Treatment results | Case load (example) | Efficient (%) |
| Recovery from illness | 7 | 20.5 |
| It is effective | 9 | 26.5 |
| Effectively | 15 | 44.2 |
| It is invalid | 3 | 8.8 |
| Amount to | 34 | 91.2 |
The effect of control group group example patient of table 3 is after treatment in 4 weeks
| Treatment results | Case load (example) | Efficient (%) |
| Recovery from illness | 2 | 5.8 |
| It is effective | 6 | 17.6 |
| Effectively | 14 | 41.2 |
| It is invalid | 11 | 35.4 |
| Amount to | 33 | 64.6 |
As a result it is 91.2% to show treatment group's total effective rate, and control group total effective rate is 64.6%, P ＜ 0.05, and difference has
It is statistically significant.
Adverse reaction：Adverse reaction is had no during medication, skin is micro- red after accidental some patientss treatment, advises patient to pay attention to water
Situation improves after temperature.Some patientss are had a blood test as, hepatic and renal function is without exception.
3.3 model case
Patient Zhang, male, 27 years old.Patient was diagnosed as the annual winter exacerbation of cold urticaria before 5 years in outer court, went out
Shi Jiyi breaks out, so that have a strong impact on its normal work.Long-term Oral Chinese holly Desloratadine piece 8.8mg, once a day, medication period
Between can reduce breaking-out probability to a certain extent, but still be difficult to return normal life.Patient's readme break out when acute pruritus, all over the body without
There is pale asphyxia wheal in rule.Readme is usually cold, and easily diarrhoea combines pale tongue after eating cold food, and tongue is white, and indentation is with crackle, deeptensepulse
It is slow.It is hypoactivity of spleen-YANG type after diagnosing.Suitable tonifying middle-Jiao and Qi is controlled, warm spleen is dispeled cold.Using the specific implementation method of the present invention, and suggest suffering from
Person keeps diet light, avoids delicious food savoury, avoids sweet food, seafood food and hot fruit.By the above-mentioned course for the treatment of of treatment 1, skin lesion is reduced,
Itch mitigates；Again after the course for the treatment of of medication 1, skin lesion, itch disappear.
Above-mentioned experiment shows that pharmaceutical composition of the present invention is evident in efficacy to alleviating cold urticaria conditions of patients.
To sum up, pharmaceutical composition of the present invention, compatibility is precise and appropriate, and each flavour of a drug complement each other, to alleviating cold urticaria patient
The state of an illness, prevent from recurring evident in efficacy, can more effectively treat cold urticaria, new choosing is provided for clinical application
Select.
Claims (7)
- A kind of 1. pharmaceutical composition for treating cold urticaria, it is characterised in that：It is by the bulk drug of following weight proportion It is prepared：Radix Astragali 25-30 parts, bighead atractylodes rhizome 15-20 parts, windproof 10-15 parts, Chinese ephedra 5-10, cassia twig 10-15 parts, RADIX ACONITI LATERALIS PREPARATA 5-10 parts, do Ginger 1-5 parts, Radix Angelicae Sinensis 10-15 parts, Ligusticum wallichii 10-15 parts, root of herbaceous peony 15-20 parts, stiff silkworm 10-15 parts, cicada slough 10-15 parts, tribulus terrestris 10- 15 parts, honey-fried licorice root 10-15 parts.
- 2. pharmaceutical composition according to claim 1, it is characterised in that：It is by following weight proportion bulk drug prepare and Into：30 parts of the Radix Astragali, 15 parts of the bighead atractylodes rhizome, windproof 10 parts, 10 parts of Chinese ephedra, 10 parts of cassia twig, 10 parts of RADIX ACONITI LATERALIS PREPARATA, 5 parts of rhizoma zingiberis, 10 parts of Radix Angelicae Sinensis, 10 parts of Ligusticum wallichii, 20 parts of the root of herbaceous peony, 10 parts of stiff silkworm, 10 parts of cicada slough, 15 parts of tribulus terrestris, 15 parts of honey-fried licorice root.
- 3. pharmaceutical composition according to claim 1 or claim 2, it is characterised in that：It is the primary medicinal powder by the bulk drug, or Person's water or extractive with organic solvent are active component, are prepared plus pharmaceutically acceptable auxiliary material or complementary composition Preparation.
- 4. pharmaceutical composition according to claim 3, it is characterised in that：The preparation is external preparation.
- 5. pharmaceutical composition according to claim 4, it is characterised in that：The external preparation be lotion, decoction, liniment, dissipate Agent or paste.
- A kind of 6. method for preparing claim 1-5 any one described pharmaceutical compositions, it is characterised in that：It includes following step Suddenly：A) bulk drug of each weight proportion is weighed；B) by the primary medicinal powder of bulk drug, or the active component of water or extractive with organic solvent, plus pharmaceutically acceptable Auxiliary material or complementary composition are prepared into preparation.
- 7. purposes of the claim 1-5 any one described pharmaceutical composition in the medicine for preparing treatment cold urticaria.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711353257.5A CN107823622A (en) | 2017-12-15 | 2017-12-15 | A kind of pharmaceutical composition for treating cold urticaria and its production and use |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711353257.5A CN107823622A (en) | 2017-12-15 | 2017-12-15 | A kind of pharmaceutical composition for treating cold urticaria and its production and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107823622A true CN107823622A (en) | 2018-03-23 |
Family
ID=61644601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711353257.5A Pending CN107823622A (en) | 2017-12-15 | 2017-12-15 | A kind of pharmaceutical composition for treating cold urticaria and its production and use |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107823622A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107875352A (en) * | 2017-12-15 | 2018-04-06 | 成都中医药大学附属医院 | A kind of pharmaceutical composition for treating acne conglobata and its production and use |
| CN115737776A (en) * | 2022-12-20 | 2023-03-07 | 杜启雪 | Chinese herbal medicine prescription for treating allergic rhinitis |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7235265B2 (en) * | 2005-10-31 | 2007-06-26 | Ross Rosen | Herbal skin formulation |
| CN103520353A (en) * | 2013-10-11 | 2014-01-22 | 成都中医药大学附属医院 | Medicament for treating urticaria, and preparation method and application thereof |
| CN105412902A (en) * | 2016-01-22 | 2016-03-23 | 王志龙 | Traditional Chinese medicine decoction for treating chronic urticaria |
| CN107875352A (en) * | 2017-12-15 | 2018-04-06 | 成都中医药大学附属医院 | A kind of pharmaceutical composition for treating acne conglobata and its production and use |
-
2017
- 2017-12-15 CN CN201711353257.5A patent/CN107823622A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7235265B2 (en) * | 2005-10-31 | 2007-06-26 | Ross Rosen | Herbal skin formulation |
| CN103520353A (en) * | 2013-10-11 | 2014-01-22 | 成都中医药大学附属医院 | Medicament for treating urticaria, and preparation method and application thereof |
| CN105412902A (en) * | 2016-01-22 | 2016-03-23 | 王志龙 | Traditional Chinese medicine decoction for treating chronic urticaria |
| CN107875352A (en) * | 2017-12-15 | 2018-04-06 | 成都中医药大学附属医院 | A kind of pharmaceutical composition for treating acne conglobata and its production and use |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107875352A (en) * | 2017-12-15 | 2018-04-06 | 成都中医药大学附属医院 | A kind of pharmaceutical composition for treating acne conglobata and its production and use |
| CN115737776A (en) * | 2022-12-20 | 2023-03-07 | 杜启雪 | Chinese herbal medicine prescription for treating allergic rhinitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107823622A (en) | A kind of pharmaceutical composition for treating cold urticaria and its production and use | |
| CN106266463A (en) | A kind of Chinese medicine composition for treating hyperuricemia and application thereof | |
| CN106266830A (en) | A kind of Chinese medicine composition treating eczema | |
| CN104306848B (en) | It is a kind of to treat the Chinese medicine composition that kidney deficiency triggers frequent micturition | |
| CN105456909A (en) | Traditional Chinese medicine composition for treating qi-stagnation and blood stasis adenomyosis | |
| CN104667249B (en) | A kind of Chinese medicine composition for treating primary dysmenorrhea | |
| CN104435545B (en) | A kind of Chinese medicine preparation for treating caused by benzene leukopenia | |
| CN107115406A (en) | A kind of hypotensor | |
| CN101401865A (en) | Chinese medicine composition for curing gout | |
| CN105456974A (en) | Traditional Chinese medicine composition for treating congealing cold blood stasis adenomyosis | |
| CN104623057A (en) | Pharmaceutical composition for treating diabetic feet and application pf pharmaceutical composition | |
| CN104324280A (en) | Traditional Chinese medicine composition for treating nasopharynx cancer and preparation method of traditional Chinese medicine composition | |
| CN106620444A (en) | Pharmaceutical composition for treating eczema and preparation method thereof | |
| CN104056231B (en) | A kind of Chinese medicine composition of cooperation western medical treatment senile skin pruritus | |
| CN108434373A (en) | A kind of Chinese medicine composition for treating acne, eczema and butterfly macules | |
| CN108524898A (en) | It is a kind of to be used to treat drug of seborrhea and preparation method thereof | |
| CN103191303A (en) | Traditional Chinese medicine for treating night sweat | |
| CN113304234B (en) | Traditional Chinese medicine composition for treating chronic renal failure | |
| CN102949653B (en) | Traditional Chinese medicine composition for treating scapulohumeral periarthritis | |
| CN101391053A (en) | Traditional Chinese medicine composition for treating hemorrhoid | |
| CN104758346A (en) | Medicine for treating migraine, as well as preparation method and preparation of medicine | |
| CN104587297A (en) | Traditional Chinese medicine capsule for treating scleroderma and preparation method thereof | |
| CN104758539A (en) | Traditional Chinese medicine composition for treating debilitation | |
| CN103550534A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN104547190A (en) | Traditional Chinese medicine for treating infantile jaundice |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180323 |